Partners Capital Investment Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Partners Capital Investment Group’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,630	Closed	-$172K	–	75
2016 Q4	$172K	Hold	1,630	–	–	0.04%	55
2016 Q3	$180K	Hold	1,630	–	–	0.04%	55
2016 Q2	$237K	Sell	1,630 -4,000	-71%	-$567K	0.07%	50
2016 Q1	$806K	Hold	5,630	–	–	0.23%	36
2015 Q4	$870K	Buy	+5,630	New	+$822K	0.29%	28

Other funds holding TARO

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Partners Capital Investment Group's TARO Position: Q1 2017 in Review

Partners Capital Investment Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2017, closing a stake of 1,630 shares — an estimated $172K sold.

Partners Capital Investment Group first reported a position in TARO in Q4 2015 and held it in 5 quarters. The position peaked at $870K in Q4 2015. 139 funds tracked by Wall St. Rank hold TARO as of Q1 2017.

Partners Capital Investment Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2017 after selling out during the quarter.
Partners Capital Investment Group sold 1,630 Taro Pharmaceutical Industries Ltd. shares in Q1 2017, an estimated $172K.
Partners Capital Investment Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 5 quarters.
Partners Capital Investment Group's Taro Pharmaceutical Industries Ltd. position peaked at $870K in Q4 2015.
139 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2017.

Based on Partners Capital Investment Group's 13F filing for Q1 2017, filed 15 May 2017.